by Claudia Li | May 13, 2021 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ May ❯ Former AstraZeneca Personalized Healthcare Strategy Leader Named Senior Vice President of Companion Diagnostics at DiaCarta FollowFollow Richmond, California, May 13, 2021. DiaCarta...
by Claudia Li | Apr 22, 2021 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ April ❯ DiaCarta’s Novel XNA Technology Rapidly Detects Raging New SARS-CoV-2 Variants FollowFollow Richmond, California, April 22, 2021. DiaCarta Inc., a precision molecular...
by Claudia Li | Apr 8, 2021 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Search ❯ Breast Cancer Panel ❯ DiaCarta Announces Publication in Nature Scientific Reports Demonstrating cfDNA Biomarker Algorithm Predicts Response and Outcome of Chemotherapy FollowFollow...
by Claudia Li | Sep 14, 2020 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ September ❯ DiaCarta’s COVID-19 Test Ranks Top 10 Among All FDA EUA Tests Based on Limit of Detection FollowFollow Richmond, California, September 2, 2020. Based on evaluation of all the...
by Claudia Li | Oct 6, 2020 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ October ❯ FDA Report: DiaCarta COVID-19 Tests Rank Top 3 Among FDA SARS-CoV-2 Reference Panel Tests FollowFollow Richmond, California, September 21, 2020. According to the recent FDA...
by Claudia Li | Jul 15, 2020 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ category ❯ Press Releases ❯ DiaCarta Receives Regulatory COFEPRIS Approval in Mexico & ICMR Approval in India for its FDA EUA Approved QuantiVirus™ SARS-CoV-2 Test FollowFollow Richmond,...
Recent Comments